China Exchanges Services Company Monthly Index Report (July)

Date 15/08/2018

Highlights

CES China A80 Index (CES A80) up 0.9 per cent, as market expects leverage levels of Mainland economy to stabilise
Pharmaceutical stocks slumped due to Mainland vaccine scandal, with CES Innovative Biotech Index (CES IBT) down 9.1 per cent
European stocks generally rallied, outperforming shares in the emerging markets
Ascletis debuted in August as first HK-listed pre-revenue biotech company
CESC launched Pan-Entertainment and Leisure Index
MOF sovereign bonds in RMB5 billion offer were oversubscribed

Click here for full details.